Feasibility of a dose-intensive CMF regimen with granulocyte colony-stimulating factor as adjuvant therapy in premenopausal patients with node-positive breast cancer

por Bos, A M E, Graaf, H de, Vries, E G E de, Piersma, H, Willemse, P H B
Publicado 2000

Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a fe...

por Veldhuis, G. J., Willemse, P. H., Beijnen, J. H., Boonstra, H., Piersma, H., van der Graaf, W. T., de Vries, E. G.
Publicado 1997

Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene

por Maring, J G, van Kuilenburg, A B P, Haasjes, J, Piersma, H, Groen, H J M, Uges, D R A, Van Gennip, A H, De Vries, E G E
Publicado 2002